In terms of treating COVID-19 patients, it is thought to interrupt the passage and intracellular assembly of SARS-CoV-2 into the target cells mediated by angiotensin-converting enzyme 2 (ACE2) receptor as well as suppressing the cytokine storm [1,7]. Here, ACE2 is linked to COVID-19.